Phase 4Completed
Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With High Cholesterol (P03434)
SCH 58235: A Multicentre, Randomised, Parallel Group, Placebo-Controlled Study Comparing the Efficacy, Safety, And Tolerability of the Daily Co-Administration of Ezetimibe 10 mg With Atorvastatin 10 mg vs. Ezetimibe Placebo With Atorvastatin 10 mg in Untreated Subjects With Primary Hypercholesterolaemia and Coronary Heart Disease
- Sponsor
- Organon and Co (Industry)
- Enrollment
- 148 enrolled
- Conditions
- Hypercholesterolemia; Atherosclerosis
- Interventions
- Ezetimibe + Atorvastatin; Atorvastatin
- Ages
- adults, older adults
- Registry
- NCT00653796
Full record on ClinicalTrials.gov
From the registry
This study was designed to assess whether co-administration of ezetimibe 10 mg with atorvastatin 10 mg in treatment naïve subjects would be more effective than treatment with atorvastatin 10 mg alone for reducing LDL-concentrations.
Primary outcomes
- Percent change in LDL-C from baseline to endpoint.
History
Last registry update
Registered
Primary completion
Started